Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
AlphaSense Honored on Inc.'s 2025 Best in Business List, Marking a Major Year for AI Innovation and Enterprise Adoption
-
Solu Therapeutics Announces Presentation of Trial in Progress on STX-0712 for Treatment of Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia at ASH Annual Meeting
-
Kumo Honored on Inc. Magazine's Best in Business List for 2025
-
Next Hydrogen Solutions Inc. Announces Change of Auditor
-
AISA Pharma Announces Completion of Enrollment in Phase 2 RECONNOITER Trial of AISA-021 in Systemic Sclerosis-Related Raynaud's Phenomenon
-
Fräsch Announces Carlos Delgado as Vice President, Sales & General Manager
-
Rehlko's all-new KD Series™ 60-600 kW generators set a new standard in reliable backup power.
-
Xona and spotit Partner to Deliver Secure Access for Critical Infrastructure Across Europe
-
Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation
-
Unlimit Launches Stable.com, the First Platform Purpose-Built to act as a Decentralized Stablecoin Clearing House
-
VinFast VF 9 - Your Home, Wherever the Road Takes You
-
TA and Relay Payments Partner to Launch Fraud‑Free Digital Fuel Payments in the U.S.
-
Yardi Launches Yardi MH Manager for Institutional Manufactured Housing Operators
-
Rocky Shore Strengthens Its Gold Anchor Project by Adding Two Significant Historical Gold Resources
-
Disneyland Resort 70th Celebration Continues in 2026 with Debut of "Bluey's Best Day Ever!," Limited-Time Events and More
-
North Developer Wins Big at DevPortal Awards
-
Clean Freak Car Wash Powered by Circle K Brings Premium Tunnel Wash Experience to Green Valley
-
Nanoscope Therapeutics' MCO-010 Optogenetic Therapy Featured at FLORetina-ICOOR 2025 Congress
-
Main Street Announces Follow-On Investment
-
McDermott Appoints Ahmed Ali Attiga to Board of Directors
-
Concord Medical Schedules 2025 Annual Meeting of Shareholders
-
CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies (DLB)
-
Moisson Montréal Completes Production of 42,000 Holiday Baskets
-
Recurrent Energy Secures Development Consent Order for the Tillbridge Solar and Battery Storage Project in the UK
-
Origin Agritech's Pioneering Hi3 Gene Editing Technology Awarded as Top 10 Major Progress in Chinese Agricultural Science for 2025, as Company Advances Commercialization
-
Lynk Pharmaceuticals Announces FDA IND Approval of Its Allosteric TYK2 Inhibitor LNK01006
-
United Natural Foods, Inc. Reports First Quarter Fiscal 2026 Results
-
iEmergent’s latest U.S. mortgage forecast validation confirms industry-leading accuracy
-
Owens & Minor to Present at Upcoming Investor Conferences on December 2, 2025
-
Armis Recognized for Innovation; Named to Inc. Best in Business List for the Second Consecutive Year
-
Pipedrive Appoints Regi Vengalil as CFO to Drive Next Stage of AI-Native Growth
-
Hirsch Unifies Global Security Operations Under One Trusted Brand
-
Tech Against Scams Coalition Launches “Scamberry Pie” to Spark Holiday Conversations About Online Safety
-
Ionis receives U.S. FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD)
-
Food Processors and Private Label Manufacturers Added to the Queue for Traceability Data Exchange Through the ReposiTrak Traceability Network
-
Comanche Biopharma Appoints Richard Colvin, MD, PhD as Global Head of R&D and John McHutchison, AO, MD as Chairman and Director of Comanche Biopharma Australia
-
D-Wave Announces Formation of U.S. Government Business Unit
-
Valo Health Appoints Rita Kale as Chief Financial Officer
-
OneSeven Named to Newsweek's Top Financial Advisory Firms 2026
-
Photonic Computing System Sets a New Benchmark for AI Computing Power and Energy Efficiency
-
CatalYm Announces First Patient Dosed in Phase 2b Trial Evaluating Visugromab in Combination with Chemoimmunotherapy as Second-Line Treatment in Metastatic Non-squamous NSCLC
-
Philip Morris International Presents at 2025 Morgan Stanley Global Consumer & Retail Conference
-
Carronade’s Nominees Present Significant Risks to Cannae Shareholders
-
GigaStar Reaches $1 Million Milestone in Creator Revenue Distributed to Investors
-
TRUE Expands Mortgage Operations Service (MOS) Platform with Post-Close & Audit Automation
-
DCCSupply Achieves PCI-Validated Point-to-Point Encryption (P2PE) Certification
-
Fully Digital Claims Processing Drives High Customer Satisfaction, but Many Customers Still Use Multiple Channels, J.D. Power Finds
-
Genomic Testing Cooperative (GTC) to Share 12 Ground-breaking Abstracts at the 2025 American Society of Hematology (ASH) Annual Meeting in Orlando
-
Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company
-
Hydreight Technologies Announces Corporate Update Highlighting Q3 Momentum, VSDHOne Acceleration, and 2026 Outlook
